randomErr quotes a report from Quartz: In the last 10 years, researchers have developed specific sniff tests for diagnosing tuberculosis, hypertension, cystic fibrosis, and even certain types of cancer. A group of global researchers led by Hossam Haick at the Israel Institute of Technology have taken the idea a step further. They’ve built a device — a kind of breathalyzer — that is compact and can diagnose up to 17 diseases from a single breath of a patient. The breathalyzer has an array of specially created gold nanoparticles, which are sized at billionths of a meter, and mixed with similar-sized tubes of carbon. These together create a network that is able to interact differently with each of the nearly 100 volatile compounds that each person breaths out (apart from gases like nitrogen, oxygen, and carbon dioxide). Haick’s team collected 2, 800 breaths from more than 1, 400 patients who were each suffering from at least one of 17 diseases (in three classes: cancer, inflammation, and neurological disorders). Each sample of the disease was then passed through the special breathalyzer, which then produced a dataset of the types of chemicals it could detect and in roughly what quantities. The team then applied artificial intelligence to the dataset to search for patterns in the types of compounds detected and the concentrations they were detected at. As they report in the journal ACS Nano, the data from the breathalyzer could be used to accurately detect that a person is suffering from a unique disease nearly nine out of ten times. Read more of this story at Slashdot.
Continued here:
Scientists Develop a Breathalyzer That Detects 17 Diseases With One Breath From a Patient
An anonymous reader quotes a report from The Inquisitr: The National Institute of Allergy and Infectious Diseases (NIAID) announced this week that a “remarkable” breakthrough has been made in the study of preventing and treating the human immunodeficiency virus (HIV), the virus that leads to acquired immunodeficiency syndrome (AIDS), according to a press release posted on the agency’s official website. The breakthrough centers around the discovery of a powerful antibody named N6 that is highly effective in both binding to the surface of the HIV virus and neutralizing it. The former has proved elusive in the past. “Identifying broadly neutralizing antibodies against HIV has been difficult because the virus rapidly changes its surface proteins to evade recognition by the immune system, ” the press release explains. The antibody was initially discovered in an HIV-positive person and has since proven to potentially neutralize 98 percent of HIV isolates, “including 16 of 20 strains resistant to other antibodies of the same class, ” according to the press release. Researchers have had previous success with other antibodies, but N6 appears to be more effective. The new discovery has potential benefits far beyond preventing and treating HIV as well. Studying exactly how N6 works could potentially lead to breakthroughs in other anti-viral antibodies. “Findings from the current study showed that N6 evolved a unique mode of binding that depends less on a variable area of the HIV envelope known as the V5 region and focuses more on conserved regions, which change relatively little among HIV strains, ” NIAID explains. “This allows N6 to tolerate changes in the HIV envelope, including the attachment of sugars in the V5 region, a major mechanism by which HIV develops resistance to other VRC01-class antibodies. Due to its potency, N6 may offer stronger and more durable prevention and treatment benefits, and researchers may be able to administer it subcutaneously (into the fat under the skin) rather than intravenously. In addition, its ability to neutralize nearly all HIV strains would be advantageous for both prevention and treatment strategies.” Read more of this story at Slashdot.
sciencehabit quotes a report from Science Magazine: A decade ago, a fossil hunter was combing the beach in southeastern England when he found a strange, brown pebble. The surface of it caught his eye: It was smooth and strangely undulating, and also slightly crinkly in some places. That oddly textured pebble, scientists report today, is actually an endocast — an impression preserved in the rock — that represents the first known evidence of fossilized brain tissue of a dinosaur (likely a close relative of Iguanodon, a large, herbivorous type of dinosaur that lived about 133 million years ago). Human brains and bird brains are packed tightly into the brain case, so that their convolutions leave an impression of the inside of the case. But dinosaur (and reptile) brains are more loosely fitted; they are surrounded within the brain case by membranes called meninges, tough sheaths that protect and support the brain. So an endocast of a dinosaur brain might be expected to show those structures — and it did. But beneath them, remineralized in calcium phosphate, the researchers also spied a pattern of tiny capillaries and other cortical tissues — the sort of fabric you’d expect for the cortex of a brain. That those textures were pressed up against the brain case doesn’t necessarily mean that dinosaurs were bigger-brained and smarter than we thought, however: Instead, the dinosaur had likely simply toppled over and been preserved upside down, its brain tissue preserved by surrounding acidic, low-oxygen waters that pickled and hardened the membranes and tissues, providing a template for mineralization. The structure of the brain, studied with scanning electron microscopes, reveal similarities to both birds and crocodiles. The researchers reported their findings in a Special Publication of the Geological Society of London. Read more of this story at Slashdot.